欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号NL/H/4625/001
药品名称Lidbree
活性成分
    • lidocaine 40.0 mg/g
剂型Intrauterine gel
上市许可持有人Gedeon Richter Plc. Gyomroi Ut 19-21 Budapest 1103 Hungary
参考成员国 - 产品名称Netherlands (NL)
Lidbree 40 mg/g, intra uteriene gel
互认成员国 - 产品名称
    • Croatia (HR)
      Lidbree 42 mg/ml intrauterini gel
    • Malta (MT)
      Lidbree 4% intrauterine gel
    • Slovenia (SI)
    • Slovakia (SK)
      Lidbree 42 mg/ml intrauterinný gél
    • Romania (RO)
    • Czechia (CZ)
      Lidbree
    • Cyprus (CY)
      Lidbree 4% intrauterine gel (40mg/g)
    • Bulgaria (BG)
    • Hungary (HU)
    • Estonia (EE)
      LIDBREE
    • Lithuania (LT)
      Lidbree 42 mg/ml gimdos ertmės gelis
    • Latvia (LV)
      Lidbree 42 mg/ml intrauterīnais gels
    • Poland (PL)
      Lidbree
    • Finland (FI)
    • Norway (NO)
    • Sweden (SE)
    • Greece (GR)
    • Italy (IT)
    • Portugal (PT)
    • Spain (ES)
    • France (FR)
    • Austria (AT)
      Lidbree 42 mg/ml Gel zur intrauterinen Anwendung
    • Ireland (IE)
    • United Kingdom (Northern Ireland) (XI)
    • Iceland (IS)
      Lidbree 42 mg/ml Leghlaup
    • Luxembourg (LU)
    • Belgium (BE)
      Lidbree
    • Denmark (DK)
    • Germany (DE)
      Lidbree 42 mg/ml Gel zur intrauterinen Anwendung
许可日期2020/06/17
最近更新日期2024/08/01
药物ATC编码
    • N01BB02 lidocaine
申请类型
  • TypeLevel1:Known Active Substance
  • TypeLevel2:Initial Application
  • TypeLevel3:Other Generic application Art 10.3 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase